These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 1981852

  • 1. Zolantidine-induced attenuation of morphine antinociception in rhesus monkeys.
    Hough LB, Nalwalk JW, Battles AH.
    Brain Res; 1990 Aug 27; 526(1):153-5. PubMed ID: 1981852
    [Abstract] [Full Text] [Related]

  • 2. Importance of histamine H2 receptors in restraint-morphine interactions.
    Nalwalk JW, Hough LB.
    Life Sci; 1995 Aug 27; 57(13):PL153-8. PubMed ID: 7674814
    [Abstract] [Full Text] [Related]

  • 3. Modulation of morphine antinociception by the brain-penetrating H2 antagonist zolantidine: detailed characterization in five nociceptive test systems.
    Nalwalk JW, Koch JE, Barke KE, Bodnar RJ, Hough LB.
    Pharmacol Biochem Behav; 1995 Mar 27; 50(3):421-9. PubMed ID: 7617681
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of morphine antinociception by centrally administered histamine H2 receptor antagonists.
    Hough LB, Nalwalk JW.
    Eur J Pharmacol; 1992 Apr 29; 215(1):69-74. PubMed ID: 1355443
    [Abstract] [Full Text] [Related]

  • 5. A role for histamine and H2-receptors in opioid antinociception.
    Gogas KR, Hough LB, Eberle NB, Lyon RA, Glick SD, Ward SJ, Young RC, Parsons ME.
    J Pharmacol Exp Ther; 1989 Aug 29; 250(2):476-84. PubMed ID: 2547933
    [Abstract] [Full Text] [Related]

  • 6. Potentiation of 2-deoxy-D-glucose antinociception, but not hyperphagia by zolantidine, a histamine (H2) receptor antagonist.
    Koch JE, Hough LB, Bodnar RJ.
    Pharmacol Biochem Behav; 1992 Feb 29; 41(2):371-6. PubMed ID: 1349437
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of naloxone-resistant antinociception by centrally administered H2-antagonists.
    Gogas KR, Hough LB.
    J Pharmacol Exp Ther; 1989 Jan 29; 248(1):262-7. PubMed ID: 2563290
    [Abstract] [Full Text] [Related]

  • 8. Effects of zolantidine a brain-penetrating H2-receptor antagonist, on naloxone-sensitive and naloxone-resistant analgesia.
    Gogas KR, Hough LB.
    Neuropharmacology; 1988 Apr 29; 27(4):357-62. PubMed ID: 2901671
    [Abstract] [Full Text] [Related]

  • 9. Effects of the histaminergic system on the morphine-induced conditioned place preference in mice.
    Suzuki T, Takamori K, Misawa M, Onodera K.
    Brain Res; 1995 Mar 27; 675(1-2):195-202. PubMed ID: 7796129
    [Abstract] [Full Text] [Related]

  • 10. Sleep variables are unaltered by zolantidine in rats: are histamine H2-receptors not involved in sleep regulation?
    Monti JM, Orellana C, Boussard M, Jantos H, Olivera S.
    Brain Res Bull; 1990 Aug 27; 25(2):229-31. PubMed ID: 1977498
    [Abstract] [Full Text] [Related]

  • 11. Antinociceptive, brain-penetrating derivatives related to improgan, a non-opioid analgesic.
    Hough LB, Nalwalk JW, Lu Q, Shan Z, Svokos K, Wentland MP, Montero MJ.
    Eur J Pharmacol; 2005 Oct 17; 522(1-3):38-46. PubMed ID: 16216240
    [Abstract] [Full Text] [Related]

  • 12. Zolantidine (SK&F 95282) is a potent selective brain-penetrating histamine H2-receptor antagonist.
    Calcutt CR, Ganellin CR, Griffiths R, Leigh BK, Maguire JP, Mitchell RC, Mylek ME, Parsons ME, Smith IR, Young RC.
    Br J Pharmacol; 1988 Jan 17; 93(1):69-78. PubMed ID: 2894879
    [Abstract] [Full Text] [Related]

  • 13. H2-receptor-mediated stress-induced analgesia is dependent on neither pituitary nor adrenal activation.
    Gogas KR, Hough LB.
    Pharmacol Biochem Behav; 1988 Jul 17; 30(3):791-4. PubMed ID: 2905473
    [Abstract] [Full Text] [Related]

  • 14. Actions of the brain-penetrating H2-antagonist zolantidine on histamine dynamics and metabolism in rat brain.
    Hough LB, Jackowski S, Eberle N, Gogas KR, Camarota NA, Cue D.
    Biochem Pharmacol; 1988 Dec 15; 37(24):4707-11. PubMed ID: 3202904
    [Abstract] [Full Text] [Related]

  • 15. Activity of the new histamine H2-receptor antagonist zolantidine at cardiac and gastric H2-receptors.
    Coruzzi G, Adami M, Pozzoli C, Poli E, Bertaccini G.
    Pharmacology; 1994 Feb 15; 48(2):69-76. PubMed ID: 7907797
    [Abstract] [Full Text] [Related]

  • 16. Further study on the effects of histamine H2 receptor agonist and antagonists on restraint-induced antinociception in mice.
    Wong JC.
    Methods Find Exp Clin Pharmacol; 1999 Feb 15; 21(6):403-7. PubMed ID: 10445232
    [Abstract] [Full Text] [Related]

  • 17. Modulation of morphine antinociception by antagonism of H2 receptors in the periaqueductal gray.
    Hough LB, Nalwalk JW.
    Brain Res; 1992 Aug 14; 588(1):58-66. PubMed ID: 1356588
    [Abstract] [Full Text] [Related]

  • 18. Different effects of the histamine H2 receptor blockers, famotidine and zolantidine, on the human atrium in vitro.
    Poli E, Pozzoli C, Barboso G, Bertaccini G.
    Arch Int Pharmacodyn Ther; 1994 Aug 14; 328(2):180-90. PubMed ID: 7710303
    [Abstract] [Full Text] [Related]

  • 19. Effects of a histamine H2 receptor agonist and antagonist on restraint-induced antinociception in female mice.
    Wong CL.
    Eur J Pharmacol; 1995 Jun 12; 279(2-3):109-13. PubMed ID: 7556390
    [Abstract] [Full Text] [Related]

  • 20. Two histamine H2 receptor antagonists, zolantidine and cimetidine, modulate nociception in cholestatic rats.
    Hasanein P.
    J Psychopharmacol; 2011 Feb 12; 25(2):281-8. PubMed ID: 19825905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.